Use of a glucose uptake enhancer to reduce cardiac damage after ischemia

摘要

A method for reducing post-ischaemic injury of the heart and/or improving the functional recovery of the heart following myocardial ischaemia comprising the administration of an effective, non-toxic amount of a thiazolidinedione glucose uptake enhancer to a human or non-human mammal in need thereof.